These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


149 related items for PubMed ID: 2136819

  • 1. Thromboxane receptor blockade attenuates the toxic effect of cyclosporine in experimental renal transplantation.
    Rossini M, Belloni A, Remuzzi G, Perico N.
    Circulation; 1990 Jan; 81(1 Suppl):I61-7; discussion I68. PubMed ID: 2136819
    [Abstract] [Full Text] [Related]

  • 2. Thromboxane receptor blockade improves cyclosporine nephrotoxicity in rats.
    Spurney RF, Mayros SD, Collins D, Ruiz P, Klotman PE, Coffman T.
    Prostaglandins; 1990 Feb; 39(2):135-46. PubMed ID: 2138344
    [Abstract] [Full Text] [Related]

  • 3. Thromboxane receptor blockade attenuates chronic cyclosporine nephrotoxicity and improves survival in rats with renal isograft.
    Perico N, Rossini M, Imberti O, Malanchini B, Cornejo RP, Gaspari F, Bertani T, Remuzzi G.
    J Am Soc Nephrol; 1992 Mar; 2(9):1398-404. PubMed ID: 1385733
    [Abstract] [Full Text] [Related]

  • 4. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate.
    Perico N, Zoja C, Benigni A, Ghilardi F, Gualandris L, Remuzzi G.
    J Pharmacol Exp Ther; 1986 Oct; 239(1):229-35. PubMed ID: 3531461
    [Abstract] [Full Text] [Related]

  • 5. Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporin A.
    Perico N, Benigni A, Zoja C, Delaini F, Remuzzi G.
    Am J Physiol; 1986 Oct; 251(4 Pt 2):F581-7. PubMed ID: 3094383
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity.
    Benigni A, Chiabrando C, Piccinelli A, Perico N, Gavinelli M, Furci L, Patino O, Abbate M, Bertani T, Remuzzi G.
    Kidney Int; 1988 Aug; 34(2):164-74. PubMed ID: 3184595
    [Abstract] [Full Text] [Related]

  • 8. Nephrotoxicity of cyclosporine A in rats with a diminished renal function.
    Provoost AP, Kaptein L, Van Aken M.
    Clin Nephrol; 1986 Aug; 25 Suppl 1():S162-7. PubMed ID: 3519023
    [Abstract] [Full Text] [Related]

  • 9. Thromboxane receptor blockade reduces renal injury in murine lupus nephritis.
    Spurney RF, Fan PY, Ruiz P, Sanfilippo F, Pisetsky DS, Coffman TM.
    Kidney Int; 1992 Apr; 41(4):973-82. PubMed ID: 1387435
    [Abstract] [Full Text] [Related]

  • 10. Pathophysiological actions of thromboxane A2 and their pharmacological antagonism by thromboxane receptor blockade with GR32191.
    Humphrey PP, Hallet P, Hornby EJ, Wallis CJ, Collington EW, Lumley P.
    Circulation; 1990 Jan; 81(1 Suppl):I42-52; discussion I59-60. PubMed ID: 2136817
    [Abstract] [Full Text] [Related]

  • 11. In vivo prostanoid formation during acute renal allograft rejection.
    Tönshoff B, Busch C, Schweer H, Schärer K, Seyberth HW.
    Nephrol Dial Transplant; 1993 Jan; 8(7):631-6. PubMed ID: 8396748
    [Abstract] [Full Text] [Related]

  • 12. Calcium entry-blockade with verapamil in cyclosporine A plus ischemia induced acute renal failure in rats.
    Iaina A, Herzog D, Cohen D, Gavendo S, Kapuler S, Serban I, Schiby G, Eliahou HE.
    Clin Nephrol; 1986 Jan; 25 Suppl 1():S168-70. PubMed ID: 3708928
    [Abstract] [Full Text] [Related]

  • 13. Hemodynamic roles of thromboxane A2 and prostaglandin E2 in glomerulonephritis.
    Stork JE, Dunn MJ.
    J Pharmacol Exp Ther; 1985 Jun; 233(3):672-8. PubMed ID: 3859644
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
    Remuzzi G, Imberti L, Rossini M, Morelli C, Carminati C, Cattaneo GM, Bertani T.
    J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
    [Abstract] [Full Text] [Related]

  • 18. Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection.
    Mangino MJ, Brunt EM, Von Doersten P, Anderson CB.
    J Pharmacol Exp Ther; 1989 Jan; 248(1):23-8. PubMed ID: 2643702
    [Abstract] [Full Text] [Related]

  • 19. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C, Ciabattoni G, Remuzzi G, Gotti E, Bombardieri S, Di Munno O, Tartarelli G, Cinotti GA, Simonetti BM, Pierucci A.
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [Abstract] [Full Text] [Related]

  • 20. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.
    Kontessis PS, Jones SL, Barrow SE, Stratton PD, Alessandrini P, De Cosmo S, Ritter JM, Viberti GC.
    J Lab Clin Med; 1993 Mar; 121(3):415-23. PubMed ID: 8445289
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.